N6-甲基腺嘌呤RNA甲基化表观遗传修饰与肾脏疾病
本文综述N6-甲基腺嘌呤(m6A)RNA甲基化修饰在肾脏疾病中的作用,介绍m6A由写入器、擦除器和读取器调控RNA剪接、稳定性、转运和翻译,并总结m6A对急性肾损伤、慢性肾脏病等的影响及未来研究方向。
要点
- m6A是真核mRNA最常见的内部修饰,调控RNA剪接、稳定性、转运和翻译。
- 催化m6A的酶分为写入器、擦除器和读取器三类。
- m6A RNA甲基化修饰在肾脏疾病发病机制中起重要作用。
核心结论
- RNA甲基化修饰尤其是m6A在肾脏疾病发病机制中发挥重要作用。
研究设计与样本
- 本文为综述,简要描述m6A并总结其对急性肾损伤和慢性肾脏病(CKD)的影响及未来可能的研究方向。
主要发现
- m6A是真核mRNA最常见的内部修饰。
- m6A基团调控RNA剪接、稳定性、转运和翻译。
- 催化m6A过程的酶被称为写入器、擦除器和读取器。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RNA methylation modification is a rapidly developing field in epigenetics. N6-methyladensine (m6A) is the most common internal modification in eukaryotic mRNA. m6A group regulates RNA splicing, stability, translocation, and translation. Enzymes catalyzing this process were termed as writers, erasers, and readers. Recent studies have focused on exploring the role of RNA methylation in human diseases. RNA methylation modifications, particularly m6A, play important roles in the pathogenesis of kidney diseases. In this review, we provide a brief description of m6A and summarize the impact of m6A on acute and chronic kidney disease (CKD) and possible future study directions for this research.
引用
- Luan J, Kopp JB, Zhou H, et al. N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases. Kidney Int Rep. 2022. PMID: 36644366. doi:10.1016/j.ekir.2022.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。